Understand the source comparison
Cerebrolysin vs Dihexa vs P21: Mechanism and Application Comparison
Cerebrolysin BDNF and NGF upregulation through neurotrophin mimicry Neurotrophin signaling cascade 5–30 mL per session, 5 days/week for 4 weeks 7–14 days (working memory tasks) Best-supported clinical evidence for cognitive enhancement; requires large-volume i
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Cerebrolysin
- BDNF and NGF upregulation through neurotrophin mimicry
- Neurotrophin signaling cascade
- 5–30 mL per session, 5 days/week for 4 weeks
- 7–14 days (working memory tasks)
- Best-supported clinical evidence for cognitive enhancement; requires large-volume injection; pre-mixed formulation eliminates reconstitution error risk
- Dihexa
- HGF receptor agonism driving synaptogenesis
- Hepatocyte growth factor pathway
- 40–160 mg subcutaneous every 2–3 days
- 14–21 days (spatial learning)
- Highest potency for synapse formation; limited human safety data; requires precise reconstitution and temperature control
- P21
- CNTF mimetic supporting cholinergic neuron survival and receptor density
- Cholinergic signaling pathway
- 1 mg/kg subcutaneous daily for 2–4 weeks
- 10–18 days (attention tasks)
- Targets age-related cholinergic decline specifically; less dramatic than Dihexa but broader safety profile in primate models